Results 181 to 190 of about 66,208 (317)

Opioid‐involved overdose trainings delivered using remote learning modalities [PDF]

, 2023
Nicholas A. Giordano, Sarah Febres‐Cordero, Helen Baker, Katherine M. Pfeiffer, Lisa Marie Walsh, Andy Gish, Sydney A. Axson   +6 more
openalex   +1 more source

Short communication: Dynamic chemical labelling allows the measurement of the paracetamol toxicity biomarker microRNA‐122 in hospital clinical laboratories

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 612-618, February 2026.
MicroRNA‐122 (miR‐122) is a sensitive biomarker for paracetamol‐induced liver injury. This study assessed the diagnostic performance of dynamic chemical labelling (DCL) combined with an immunoassay platform to quantify miR‐122 in human serum, as a proof‐of‐concept for hospital use.
Samar Alzeer, Antonio Marin‐Romero, Bárbara López‐Longarela, Juan J. Guardia‐Monteagudo, F. Javier Lopez‐Delgado, Salvatore Pernagallo, Juan J. Diaz‐Mochon, Mavys Tabraue‐Chavez, Kathleen Scullion, James W. Dear   +9 more
wiley   +1 more source

Association of Opioid Overdose With Opioid Prescriptions to Family Members [PDF]

, 2019
Nazleen F. Khan, Brian T. Bateman, Joan Landon, Joshua J. Gagne   +3 more
openalex   +1 more source

Prevalence and correlates of experiencing drug-related discrimination among people who use drugs presenting at emergency department at high risk of opioid overdose

, 2023
Shayla Nolen, Taneisha Wilson, Brendan Jacka, Yu Li, Francesca L. Beaudoin, Brandon D. L. Marshall   +5 more
openalex   +1 more source

One-Year Mortality and Associated Factors in Patients Receiving Out-of-Hospital Naloxone for Presumed Opioid Overdose [PDF]

, 2020
Nicklaus P. Ashburn, Christopher W. Ryder, Ryan M. Angi, Anna C. Snavely, R. Darrell Nelson, William P. Bozeman, Henderson D. McGinnis, James Winslow, Jason P. Stopyra   +8 more
openalex   +1 more source

EE417 Real-World Economic Benefit Administering Naloxone Among Patients with High and Low Dose Opioid Overdose [PDF]

, 2022
A Changolkar, MK Sindhwani, G Owens
openalex   +1 more source

Clinical and Financial Impact of Addiction Medicine Pharmacy Specialist

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 2, February 2026.
ABSTRACT Background Pain management in patients with substance use disorder (SUD) is complex and often under‐addressed in inpatient settings. Clinical pharmacy specialists (CPS) with expertise in pain management and addiction medicine can play a critical role in closing this care gap. To quantify and describe the clinical and financial impact of a Pain
Emily R. Casey, Jacob Radcliff, Tanya J. Uritsky   +2 more
wiley   +1 more source

Clinical factors linked to xylazine exposure in emergency department patients with illicit opioid overdose. [PDF]

Addiction
Love JS, Vargas-Torres C, Aldy K, Brent J, Wax P, Culbreth R, Krotulski A, Campleman S, Logan B, Abston S, Li S, Manini AF, Fentalog Study Group.   +12 more
europepmc   +1 more source

Expanding Access to Opioid Use Disorder Treatment: Low‐Threshold Buprenorphine Dispensing via an Interprofessional Mobile Medical Unit in Chicago

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 2, February 2026.
ABSTRACT Background Less than 25% of individuals with opioid use disorder access medication treatment. Lower income and segregated Black and Hispanic communities often have little to no access to services. In 2021, the Drug Enforcement Administration authorized opioid treatment programs to add mobile units to their licensure, extending treatment to ...
Abigail T. Elmes‐Patel, Jennie B. Jarrett, Antonio D. Jimenez, Stockton M. Mayer, Sarah E. Messmer   +4 more
wiley   +1 more source

Paraspinal Compartment Syndrome Associated with Opioid Overdose: A Case Report. [PDF]

Clin Pract Cases Emerg Med
Habiyaremye T, Holz K, Jackson JR.
europepmc   +1 more source